DVHGFDevonian Health Group Inc - Ordinary Shares (Sub Voting)
DVHGF
Devonian Health Group Inc - Ordinary Shares (Sub Voting)2
Mkt Cap
$11.8MVolume
25.0052W High
$0.1852W Low
$0.0711PE Ratio
-2.19DVHGF Fundamentals
Price
$0.0711Prev Close
$0.18Open
$0.071150D MA
$0.0711Beta
0.00Avg. Volume
0.00EPS (Annual)
-$0.0291P/B
1.72Devonian Health Group, Inc. is a clinical-stage pharmaceutical company. The firm is engaged in the development of drugs for a range of autoimmune and fibroinflammatory conditions, using novel therapeutic approaches to address unmet medical needs. It offers therapeutic and cosmeceutical products. Its drug candidate, Thykamine product is issued from Devonian’s SUPREX platform, is a product for the prevention and treatment of health conditions related to inflammation and oxidative stress including ulcerative colitis, atopic dermatitis, psoriasis, rheumatoid arthritis, and other autoimmune disorders. The company was founded by Andre P. Boulet on March 27, 2015 and is headquartered in Montmagny, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Devonian Health Group Inc - Ordinary Shares - New?
What is the 52-week high for Devonian Health Group Inc - Ordinary Shares - New?
What is the 52-week low for Devonian Health Group Inc - Ordinary Shares - New?
What is Devonian Health Group Inc - Ordinary Shares - New stock price today?
What was Devonian Health Group Inc - Ordinary Shares - New stock price yesterday?
What is the PE ratio of Devonian Health Group Inc - Ordinary Shares - New?
What is the Price-to-Book ratio of Devonian Health Group Inc - Ordinary Shares - New?
What is the 50-day moving average of Devonian Health Group Inc - Ordinary Shares - New?